181 related articles for article (PubMed ID: 33053391)
1. Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention.
Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Matsushita K; Tsujita K
Int J Cardiol; 2021 Feb; 325():121-126. PubMed ID: 33053391
[TBL] [Abstract][Full Text] [Related]
2. Japanese high bleeding risk criteria status predicts low thrombogenicity and bleeding events in patients undergoing percutaneous coronary intervention.
Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Yamamoto E; Soejima H; Matsushita K; Tsujita K
Cardiovasc Interv Ther; 2023 Jul; 38(3):299-308. PubMed ID: 36877333
[TBL] [Abstract][Full Text] [Related]
3. Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease.
Mitsuse T; Kaikita K; Ishii M; Oimatsu Y; Nakanishi N; Ito M; Arima Y; Sueta D; Iwashita S; Fujisue K; Kanazawa H; Takashio S; Araki S; Usuku H; Suzuki S; Sakamoto K; Yamamoto E; Soejima H; Tsujita K
J Atheroscler Thromb; 2020 Mar; 27(3):215-225. PubMed ID: 31391352
[TBL] [Abstract][Full Text] [Related]
4. Hemodialysis-related low thrombogenicity measured by total thrombus-formation analysis system in patients undergoing percutaneous coronary intervention.
Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejimaa H; Matsushita K; Tsujita K
Thromb Res; 2021 Apr; 200():141-148. PubMed ID: 33610886
[TBL] [Abstract][Full Text] [Related]
5. Malnutrition-associated high bleeding risk with low thrombogenicity in patients undergoing percutaneous coronary intervention.
Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Matsushita K; Tsujita K
Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1227-1235. PubMed ID: 35197212
[TBL] [Abstract][Full Text] [Related]
6. Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
Ito M; Kaikita K; Sueta D; Ishii M; Oimatsu Y; Arima Y; Iwashita S; Takahashi A; Hoshiyama T; Kanazawa H; Sakamoto K; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Hokimoto S; Yamabe H; Ogawa H
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811167
[TBL] [Abstract][Full Text] [Related]
7. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
[TBL] [Abstract][Full Text] [Related]
8. Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
Oimatsu Y; Kaikita K; Ishii M; Mitsuse T; Ito M; Arima Y; Sueta D; Takahashi A; Iwashita S; Yamamoto E; Kojima S; Hokimoto S; Tsujita K
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438734
[TBL] [Abstract][Full Text] [Related]
9. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M
J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
[TBL] [Abstract][Full Text] [Related]
11. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
[TBL] [Abstract][Full Text] [Related]
12. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
[TBL] [Abstract][Full Text] [Related]
13. Comparison of original and modified Academic Research Consortium for High Bleeding Risk definitions in real-world practice.
Takahashi K; Miura K; Shima Y; Okabe K; Ikuta A; Taguchi Y; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
J Cardiol; 2022 Aug; 80(2):155-161. PubMed ID: 35282943
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L
EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586
[TBL] [Abstract][Full Text] [Related]
15. PRECISE-DAPT and ARC-HBR Predict in-Hospital Outcomes in Patients Who Underwent Percutaneous Coronary Intervention.
Kadiyala V; Long S; Has P; Lima FV; Sherrod CF; Heinl R; Williams MU; Nowak E; Kennedy K; Aronow HD; Abbott JD
Am J Cardiol; 2023 Mar; 191():43-50. PubMed ID: 36640599
[TBL] [Abstract][Full Text] [Related]
16. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention.
Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A
Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751
[TBL] [Abstract][Full Text] [Related]
17. Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: Start with what is right rather than what is acceptable.
Nakamura M; Iijima R
J Cardiol; 2021 Aug; 78(2):91-98. PubMed ID: 33358236
[TBL] [Abstract][Full Text] [Related]
18. Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2.
Garot P; Neylon A; Morice MC; Tamburino C; Bleiziffer S; Thiele H; Scholtz S; Schramm R; Cockburn J; Cunnington M; Wolf A; Barbanti M; Tchetché D; Pagnotta P; Gilard M; Bedogni F; Van Belle E; Vasa-Nicotera M; Chieffo A; Bogaerts K; Hengstenberg C; Capodanno D
EuroIntervention; 2022 Aug; 18(6):503-513. PubMed ID: 35450838
[TBL] [Abstract][Full Text] [Related]
19. PRECISE-DAPT, ARC-HBR, or Simplified Clinical Evaluation for the Prediction of Major Bleeding After Percutaneous Coronary Intervention in older Patients.
Marschall AF; Duarte Torres J; Biscotti Rodíl B; Gómez Sánchez I; Basabe Velasco E; Ramos Alejos-Pita C; López Soberón E; Suárez Cuervo A; Álvarez Antón S; de la Torre Hernández JM; Martí Sánchez D
Am J Cardiol; 2024 May; 219():103-109. PubMed ID: 38552712
[TBL] [Abstract][Full Text] [Related]
20. Increased thrombogenicity is associated with revascularization outcomes in patients with chronic limb-threatening ischemia.
Kuyama N; Kaikita K; Ishii M; Mitsuse T; Nakanishi N; Fujisue K; Otsuka Y; Hanatani S; Sueta D; Takashio S; Araki S; Yamamoto E; Matsushita K; Tsujita K
J Vasc Surg; 2022 Aug; 76(2):513-522.e3. PubMed ID: 35390483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
